Week of July 16, 2024 | Vol. 13, Issue 29

Upcoming Events

Industry Activity

M&A Transactions

Featured Chart

Medicare Advantage Still Shines Despite Utilization (and Reimbursement) Concerns

Note: Gross margins per enrollee are the amount by which total premium income exceeds total claims costs, divided by the number of enrollees. Gross margins include administrative costs, tax liability, and profits.

Source: Analysis of data from the Kaiser Family Foundation (June 2024)

Trading Comps

Market Research

M&A Pipeline

For more information about our active deals, please reach out to the following:

Pharmaceuticals



Robert Stanley

Director

Carson Riley

Vice President

Pharma Services



Todd Bokus

Director

Jake Curtis

Vice President

Healthcare & Pharmacy Services

Aaron Olson

Managing Director, Head of Healthcare Services

Featured Headlines

Aterian Investment Partners Acquires Contract Pharmaceuticals Limited

Aterian

Tergus Pharma merges with fellow dermatology CDMO MedPharm

Fierce Pharma

Health care industry pushes back against cybersecurity proposal

Axios

Carlyle to Acquire Baxter’s kidney care unit in a $4bn Valued Deal

PE Insights

House Speaker Mike Johnson pledges vote for BIOSECURE as China-targeting bill hangs in limbo

Fierce Pharma

Lifecore Biomedical Announces Cooperation Agreement with 22NW

Yahoo Finance

Thermo Fisher Scientific Completes Acquisition of Olink, Announces Commencement of Subsequent Offering Period

Business Wire

May River Capital Completes Sale Of NSL Analytical Services

May River Capital

Recent Transactions